MDT insider transaction filings
Medtronic plc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-04. Screen MDT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Thompson Kweli — EVP & President, Neuroscience | Tax withholding (F): 1,739 @ $85.39 · Grant/award (A): 6,923 @ $0 · Grant/award (A): 17,306 (derivative) @ $0 · Grant/award (A): 49,167 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Walter Matthew R. — SVP, Chief HR Officer | Tax withholding (F): 1,675 @ $85.39 · Grant/award (A): 5,769 @ $0 · Grant/award (A): 14,421 (derivative) @ $0 · Grant/award (A): 40,973 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Blomquist Denise L. — Chief Accounting Officer | Tax withholding (F): 212 @ $85.39 · Grant/award (A): 2,337 @ $0 · Grant/award (A): 2,337 (derivative) @ $0 · Grant/award (A): 1,366 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Martha Geoffrey — Chairman and CEO, Director | Tax withholding (F): 15,810 @ $85.39 · Grant/award (A): 41,533 @ $0 · Grant/award (A): 103,831 (derivative) @ $0 · Grant/award (A): 295,002 (derivative) @ $0 · Grant/award (A): 273,150 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | KIIL HARRY SKIP — EVP & President Cardiovascular | Tax withholding (F): 3,074 @ $85.39 · Grant/award (A): 9,230 @ $0 · Grant/award (A): 23,074 (derivative) @ $0 · Grant/award (A): 65,556 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Marinaro Michael — EVP, Pres MedSurg and Americas | Tax withholding (F): 3,356 @ $85.39 · Grant/award (A): 10,960 @ $0 · Grant/award (A): 46,147 @ $0 · Grant/award (A): 27,400 (derivative) @ $0 · Grant/award (A): 77,848 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Pieton Thierry — EVP & Chief Financial Officer | Grant/award (A): 11,537 @ $0 · Grant/award (A): 28,842 (derivative) @ $0 · Grant/award (A): 81,945 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Quinn Michelle — EVP, GC and Secretary | Grant/award (A): 6,346 @ $0 · Grant/award (A): 15,863 (derivative) @ $0 · Grant/award (A): 45,070 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | Quinn Michelle — EVP, GC and Secretary | Tax withholding (F): 2,069 @ $86.88 | EDGAR |
| 2026-07-09 | 4 | Walter Matthew R. — SVP, Chief HR Officer | Sale (S): 3,102 @ $83.15 | EDGAR |
| 2026-06-09 | 4 | KIIL HARRY SKIP — EVP & President Cardiovascular | Sale (S): 3,961 @ $80.44 · Sale (S): 228 @ $80.45 | EDGAR |
| 2026-06-08 | 4 | Blomquist Denise L. — Chief Accounting Officer | Tax withholding (F): 237 @ $83.32 | EDGAR |
| 2026-06-08 | 4 | Walter Matthew R. — SVP, Chief HR Officer | Tax withholding (F): 2,840 @ $83.32 | EDGAR |
| 2026-06-08 | 4 | Marinaro Michael — EVP, Pres MedSurg and Americas | Tax withholding (F): 7,471 @ $83.32 | EDGAR |
| 2026-06-08 | 4 | KIIL HARRY SKIP — EVP & President Cardiovascular | Tax withholding (F): 6,817 @ $83.32 | EDGAR |
| 2026-06-08 | 4 | Martha Geoffrey — Chairman and CEO, Director | Tax withholding (F): 41,936 @ $83.32 | EDGAR |
| 2026-05-28 | 4 | Blomquist Denise L. — Chief Accounting Officer | Option exercise (M): 1,712 @ $0 · Option exercise (M): 1,621 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Walter Matthew R. — SVP, Chief HR Officer | Option exercise (M): 9,149 @ $0 · Option exercise (M): 8,449 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Marinaro Michael — EVP, Pres MedSurg and Americas | Option exercise (M): 18,994 @ $0 · Option exercise (M): 17,093 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | KIIL HARRY SKIP — EVP & President Cardiovascular | Option exercise (M): 15,195 @ $0 · Option exercise (M): 14,517 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Martha Geoffrey — Chairman and CEO, Director | Option exercise (M): 94,963 @ $0 · Option exercise (M): 85,461 (derivative) @ $0 | EDGAR |
| 2026-05-28 | 4 | Wall Brett A. — EVP & Pres Neuroscience | Option exercise (M): 26,907 @ $0 · Option exercise (M): 24,214 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Walter Matthew R. — SVP, Chief HR Officer | Tax withholding (F): 35 @ $80 | EDGAR |
| 2026-04-29 | 4 | Lee Joon Sup — Director | Grant/award (A): 1,803 @ $0 | EDGAR |
| 2026-04-29 | 4 | Blomquist Denise L. — Chief Accounting Officer | Grant/award (A): 1,508 @ $0 · Tax withholding (F): 318 @ $81.90 | EDGAR |
| 2026-04-29 | 4 | Lewis Gregory P — Director | Grant/award (A): 2,111 @ $0 · Tax withholding (F): 207 @ $81.90 | EDGAR |
| 2026-04-29 | 4 | NABEL ELIZABETH G — Director | Grant/award (A): 2,111 @ $0 · Tax withholding (F): 207 @ $81.90 | EDGAR |
| 2026-04-29 | 4 | Groetelaars John P — Director | Grant/award (A): 1,444 @ $0 | EDGAR |
| 2026-04-29 | 4 | Lofton Kevin E — Director | Grant/award (A): 2,111 @ $0 · Tax withholding (F): 207 @ $81.90 | EDGAR |
| 2026-04-29 | 4 | Fonseca Lidia — Director | Grant/award (A): 2,111 @ $0 · Tax withholding (F): 207 @ $81.90 | EDGAR |
| 2026-04-29 | 4 | Powell Kendall J — Director | Grant/award (A): 2,111 @ $0 · Tax withholding (F): 207 @ $81.90 | EDGAR |
| 2026-04-29 | 4 | DONNELLY SCOTT C — Director | Grant/award (A): 2,111 @ $0 · Tax withholding (F): 207 @ $81.90 | EDGAR |
| 2026-04-29 | 4 | Jellison William R — Director | Grant/award (A): 1,444 @ $0 | EDGAR |
| 2026-04-29 | 4 | HOGAN RANDALL J — Director | Grant/award (A): 2,111 @ $0 · Tax withholding (F): 207 @ $81.90 | EDGAR |
| 2026-04-29 | 4 | ARNOLD CRAIG — Director | Grant/award (A): 2,111 @ $0 · Tax withholding (F): 207 @ $81.90 | EDGAR |
| 2026-03-05 | 4 | Pieton Thierry — EVP & Chief Financial Officer | Tax withholding (F): 2,976 @ $96.71 | EDGAR |
| 2026-02-26 | 4 | KIIL HARRY SKIP — EVP & President Cardiovascular | Option exercise (M): 30,568 @ $93.08 · Option exercise (M): 19,923 @ $87.76 · Option exercise (M): 385 @ $80 · Sale (S): 1,648 @ $97.86 · Sale (S): 30,568 @ $97.66 · Sale (S): 19,255 @ $97.77 · +5 more | EDGAR |
| 2026-02-24 | 4 | Blomquist Denise L. — Chief Accounting Officer | Gift (G): 340 @ $0 | EDGAR |
| 2026-02-02 | 4 | Blomquist Denise L. — Chief Accounting Officer | Tax withholding (F): 148 @ $101 | EDGAR |
| 2025-12-17 | 4 | Marinaro Michael — EVP, Pres MedSurg and Americas | Tax withholding (F): 1,371 @ $99.87 | EDGAR |
| 2025-12-17 | 4 | Martha Geoffrey — Chairman and CEO, Director | Tax withholding (F): 1,564 @ $99.87 | EDGAR |
| 2025-12-17 | 4 | Wall Brett A. — EVP & Pres Neuroscience | Tax withholding (F): 439 @ $99.87 | EDGAR |
| 2025-12-09 | 4 | KIIL HARRY SKIP — EVP & President Cardiovascular | Tax withholding (F): 1,702 @ $101.36 | EDGAR |
| 2025-11-24 | 4 | Blomquist Denise L. — Chief Accounting Officer | Gift (G): 170 @ $0 | EDGAR |
| 2025-11-21 | 4 | Smith Gregory L — EVP Global Ops & Supply Chain | Sale (S): 24,186 @ $101.93 · Sale (S): 1,942 @ $101.99 · Sale (S): 1,995 @ $102.03 · Sale (S): 825 @ $102.04 · Sale (S): 227 @ $102.05 · Sale (S): 325 @ $102.06 · +1 more | EDGAR |
| 2025-09-05 | 4 | KIIL HARRY SKIP — EVP & President Cardiovascular | Sale (S): 8,405 @ $91.58 · Sale (S): 200 @ $91.59 | EDGAR |
| 2025-08-25 | 4 | Jellison William R — Director | Purchase (P): 2,500 @ $92.73 · Purchase (P): 2,500 @ $92.37 | EDGAR |
| 2025-08-21 | 4 | Marinaro Michael — EVP, Pres MedSurg and Americas | Tax withholding (F): 1,052 @ $93.22 | EDGAR |
| 2025-08-04 | 4 | Walter Matthew R. — SVP, Chief HR Officer | Option exercise (M): 2,179 @ $0 · Tax withholding (F): 667 @ $89.34 · Tax withholding (F): 364 @ $89.34 · Option exercise (M): 963 @ $78 · Tax withholding (F): 879 @ $89.34 · Option exercise (M): 2,179 (derivative) @ $0 · +1 more | EDGAR |
| 2025-08-04 | 4 | Marinaro Michael — EVP, Pres MedSurg and Americas | Option exercise (M): 6,535 @ $0 · Tax withholding (F): 3,158 @ $89.34 · Tax withholding (F): 1,741 @ $89.34 · Option exercise (M): 3,126 @ $78 · Tax withholding (F): 2,864 @ $89.34 · Option exercise (M): 6,535 (derivative) @ $0 · +1 more | EDGAR |
Recent 8-K events — Medtronic plc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-06-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-02-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-18 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-10-21 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-16 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MDT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →